Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction

OBJECTIVE: Recent studies suggest that excess dietary fructose contributes to metabolic dysfunction by promoting insulin resistance, de novo lipogenesis (DNL), and hepatic steatosis, thereby increasing the risk of obesity, type 2 diabetes (T2D), non-alcoholic steatohepatitis (NASH), and related como...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutierrez, Jemy A., Liu, Wei, Perez, Sylvie, Xing, Gang, Sonnenberg, Gabriele, Kou, Kou, Blatnik, Matt, Allen, Richard, Weng, Yan, Vera, Nicholas B., Chidsey, Kristin, Bergman, Arthur, Somayaji, Veena, Crowley, Collin, Clasquin, Michelle F., Nigam, Anu, Fulham, Melissa A., Erion, Derek M., Ross, Trenton T., Esler, William P., Magee, Thomas V., Pfefferkorn, Jeffrey A., Bence, Kendra K., Birnbaum, Morris J., Tesz, Gregory J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050029/
https://www.ncbi.nlm.nih.gov/pubmed/33667726
http://dx.doi.org/10.1016/j.molmet.2021.101196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050029/
https://www.ncbi.nlm.nih.gov/pubmed/33667726
http://dx.doi.org/10.1016/j.molmet.2021.101196

Ejemplares similares